India releases hydroxychloroquine stocks amid pressure from Trump
by Hannah Ellis-Petersen South Asia correspondent from on (#51THP)
US president called Modi and threatened 'retaliation' if country kept full export ban
India has approved some exports of hydroxychloroquine, an anti-malaria drug being touted as a possible coronavirus treatment, after apparent pressure from Donald Trump, who has been urging Americans to take it.
The tablets are used to prevent and treat malaria, lupus and rheumatoid arthritis but over the past week the US president has been aggressively promoting the drug as a treatment for coronavirus, despite there being no conclusive medical evidence to prove its efficacy.
Continue reading...